HEADER TRANSFERASE 20-MAY-15 4ZXT TITLE COMPLEX OF ERK2 WITH CATECHOL COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MAPK 1, ERT1, EXTRACELLULAR SIGNAL-REGULATED KINASE 2, ERK- COMPND 5 2, MAP KINASE ISOFORM P42, P42-MAPK, MITOGEN-ACTIVATED PROTEIN KINASE COMPND 6 2, MAPK 2; COMPND 7 EC: 2.7.11.24; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAPK1, ERK2, PRKM1, PRKM2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21-CODONPLUS(DE3)-RIPL; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS CATECHOL COMPLEX, MITOGEN-ACTIVATED PROTEIN KINASE, SIGNAL-REGULATED KEYWDS 2 KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR I.KURINOV,M.MALAKHOVA REVDAT 3 16-OCT-24 4ZXT 1 REMARK REVDAT 2 05-OCT-16 4ZXT 1 JRNL REVDAT 1 25-MAY-16 4ZXT 0 JRNL AUTH Y.LIM DO,S.H.SHIN,M.H.LEE,M.MALAKHOVA,I.KURINOV,Q.WU,J.XU, JRNL AUTH 2 Y.JIANG,Z.DONG,K.LIU,K.Y.LEE,K.B.BAE,B.Y.CHOI,Y.DENG,A.BODE, JRNL AUTH 3 Z.DONG JRNL TITL A NATURAL SMALL MOLECULE, CATECHOL, INDUCES C-MYC JRNL TITL 2 DEGRADATION BY DIRECTLY TARGETING ERK2 IN LUNG CANCER. JRNL REF ONCOTARGET V. 7 35001 2016 JRNL REFN ESSN 1949-2553 JRNL PMID 27167001 JRNL DOI 10.18632/ONCOTARGET.9223 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.8.1_1168 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.77 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.390 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 25363 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.155 REMARK 3 R VALUE (WORKING SET) : 0.153 REMARK 3 FREE R VALUE : 0.183 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1269 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 43.7760 - 4.1592 1.00 2735 145 0.1693 0.1659 REMARK 3 2 4.1592 - 3.3016 1.00 2691 141 0.1420 0.1641 REMARK 3 3 3.3016 - 2.8844 1.00 2672 141 0.1546 0.2079 REMARK 3 4 2.8844 - 2.6207 1.00 2705 142 0.1499 0.1864 REMARK 3 5 2.6207 - 2.4329 1.00 2657 141 0.1433 0.1783 REMARK 3 6 2.4329 - 2.2894 1.00 2645 139 0.1392 0.1966 REMARK 3 7 2.2894 - 2.1748 1.00 2706 141 0.1466 0.2054 REMARK 3 8 2.1748 - 2.0801 1.00 2673 141 0.1560 0.1992 REMARK 3 9 2.0801 - 2.0000 0.98 2610 138 0.1651 0.2308 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.190 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 17.920 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.012 2975 REMARK 3 ANGLE : 1.329 4037 REMARK 3 CHIRALITY : 0.080 438 REMARK 3 PLANARITY : 0.007 519 REMARK 3 DIHEDRAL : 14.530 1131 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: (CHAIN A AND RESID 7:109) REMARK 3 ORIGIN FOR THE GROUP (A): -13.5686 12.2244 31.8880 REMARK 3 T TENSOR REMARK 3 T11: 0.3473 T22: 0.3512 REMARK 3 T33: 0.2570 T12: 0.0529 REMARK 3 T13: -0.0124 T23: 0.0385 REMARK 3 L TENSOR REMARK 3 L11: 3.0633 L22: 1.1162 REMARK 3 L33: 4.8175 L12: -1.1041 REMARK 3 L13: -0.2490 L23: -1.5091 REMARK 3 S TENSOR REMARK 3 S11: 0.0096 S12: 0.0923 S13: 0.5949 REMARK 3 S21: 0.2115 S22: 0.1705 S23: -0.0208 REMARK 3 S31: -0.8269 S32: -0.6144 S33: -0.1017 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: (CHAIN A AND RESID 110:336) REMARK 3 ORIGIN FOR THE GROUP (A): 0.2663 6.8649 55.7652 REMARK 3 T TENSOR REMARK 3 T11: 0.1289 T22: 0.0892 REMARK 3 T33: 0.1482 T12: 0.0371 REMARK 3 T13: 0.0301 T23: 0.0067 REMARK 3 L TENSOR REMARK 3 L11: 2.8753 L22: 0.7419 REMARK 3 L33: 1.0558 L12: 1.0536 REMARK 3 L13: 0.7666 L23: 0.0715 REMARK 3 S TENSOR REMARK 3 S11: 0.0280 S12: 0.0670 S13: 0.1252 REMARK 3 S21: -0.0223 S22: 0.0127 S23: -0.0249 REMARK 3 S31: -0.0101 S32: 0.0485 S33: -0.0358 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: (CHAIN A AND RESID 337:357) REMARK 3 ORIGIN FOR THE GROUP (A): -2.9752 6.4494 23.4623 REMARK 3 T TENSOR REMARK 3 T11: 0.2315 T22: 0.2420 REMARK 3 T33: 0.1260 T12: 0.0383 REMARK 3 T13: 0.0001 T23: 0.0403 REMARK 3 L TENSOR REMARK 3 L11: 7.8312 L22: 8.0713 REMARK 3 L33: 6.7103 L12: 2.9920 REMARK 3 L13: -0.0597 L23: -0.5496 REMARK 3 S TENSOR REMARK 3 S11: 0.2279 S12: 0.7161 S13: -0.2672 REMARK 3 S21: -0.2276 S22: -0.0402 S23: -0.3202 REMARK 3 S31: 0.1234 S32: 0.5430 S33: -0.1838 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4ZXT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-MAY-15. REMARK 100 THE DEPOSITION ID IS D_1000210087. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 31-MAY-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 24-ID-C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9793 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25363 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 4.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 28.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.07 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.28 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.1-1.3 M AMMONIUM SULFATE, 2% PEG500 REMARK 280 MME, 0.1 M HEPES/NAOH, CRYSTALS SOAKED IN PRECIPITANT SOLUTION REMARK 280 CONTAINING 2.5 MM CATECHOL IN 2.5% DMSO FOR ONE WEEK, PH 7.5, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 34.67050 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1000 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16780 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -22.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 ALA A 3 REMARK 465 ALA A 4 REMARK 465 ALA A 5 REMARK 465 ALA A 6 REMARK 465 TYR A 358 REMARK 465 ARG A 359 REMARK 465 SER A 360 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 12 CG CD OE1 OE2 REMARK 470 MET A 13 CG SD CE REMARK 470 VAL A 14 CG1 CG2 REMARK 470 ARG A 15 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD2 ASP A 167 O HOH A 501 1.94 REMARK 500 O HOH A 755 O HOH A 770 1.99 REMARK 500 O3 SO4 A 404 O HOH A 502 2.07 REMARK 500 O HOH A 502 O HOH A 762 2.09 REMARK 500 O1 SO4 A 403 O HOH A 503 2.14 REMARK 500 O HOH A 697 O HOH A 734 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 11 C - N - CA ANGL. DEV. = 9.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 11 -132.40 -35.78 REMARK 500 GLU A 12 -121.20 73.66 REMARK 500 VAL A 14 36.08 86.67 REMARK 500 ARG A 15 83.35 45.51 REMARK 500 ASN A 27 152.20 87.77 REMARK 500 ARG A 148 -0.36 74.80 REMARK 500 ASP A 149 43.70 -144.68 REMARK 500 ASP A 167 81.00 68.13 REMARK 500 ASP A 175 71.31 -150.73 REMARK 500 ASN A 201 15.77 -157.55 REMARK 500 LEU A 294 48.74 -98.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASN A 27 LEU A 28 -142.40 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CAQ A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NH4 A 405 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NH4 A 406 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4N0S RELATED DB: PDB DBREF 4ZXT A 1 360 UNP P28482 MK01_HUMAN 1 360 SEQRES 1 A 360 MET ALA ALA ALA ALA ALA ALA GLY ALA GLY PRO GLU MET SEQRES 2 A 360 VAL ARG GLY GLN VAL PHE ASP VAL GLY PRO ARG TYR THR SEQRES 3 A 360 ASN LEU SER TYR ILE GLY GLU GLY ALA TYR GLY MET VAL SEQRES 4 A 360 CYS SER ALA TYR ASP ASN VAL ASN LYS VAL ARG VAL ALA SEQRES 5 A 360 ILE LYS LYS ILE SER PRO PHE GLU HIS GLN THR TYR CYS SEQRES 6 A 360 GLN ARG THR LEU ARG GLU ILE LYS ILE LEU LEU ARG PHE SEQRES 7 A 360 ARG HIS GLU ASN ILE ILE GLY ILE ASN ASP ILE ILE ARG SEQRES 8 A 360 ALA PRO THR ILE GLU GLN MET LYS ASP VAL TYR ILE VAL SEQRES 9 A 360 GLN ASP LEU MET GLU THR ASP LEU TYR LYS LEU LEU LYS SEQRES 10 A 360 THR GLN HIS LEU SER ASN ASP HIS ILE CYS TYR PHE LEU SEQRES 11 A 360 TYR GLN ILE LEU ARG GLY LEU LYS TYR ILE HIS SER ALA SEQRES 12 A 360 ASN VAL LEU HIS ARG ASP LEU LYS PRO SER ASN LEU LEU SEQRES 13 A 360 LEU ASN THR THR CME ASP LEU LYS ILE CME ASP PHE GLY SEQRES 14 A 360 LEU ALA ARG VAL ALA ASP PRO ASP HIS ASP HIS THR GLY SEQRES 15 A 360 PHE LEU THR GLU TYR VAL ALA THR ARG TRP TYR ARG ALA SEQRES 16 A 360 PRO GLU ILE MET LEU ASN SER LYS GLY TYR THR LYS SER SEQRES 17 A 360 ILE ASP ILE TRP SER VAL GLY CYS ILE LEU ALA GLU MET SEQRES 18 A 360 LEU SER ASN ARG PRO ILE PHE PRO GLY LYS HIS TYR LEU SEQRES 19 A 360 ASP GLN LEU ASN HIS ILE LEU GLY ILE LEU GLY SER PRO SEQRES 20 A 360 SER GLN GLU ASP LEU ASN CME ILE ILE ASN LEU LYS ALA SEQRES 21 A 360 ARG ASN TYR LEU LEU SER LEU PRO HIS LYS ASN LYS VAL SEQRES 22 A 360 PRO TRP ASN ARG LEU PHE PRO ASN ALA ASP SER LYS ALA SEQRES 23 A 360 LEU ASP LEU LEU ASP LYS MET LEU THR PHE ASN PRO HIS SEQRES 24 A 360 LYS ARG ILE GLU VAL GLU GLN ALA LEU ALA HIS PRO TYR SEQRES 25 A 360 LEU GLU GLN TYR TYR ASP PRO SER ASP GLU PRO ILE ALA SEQRES 26 A 360 GLU ALA PRO PHE LYS PHE ASP MET GLU LEU ASP ASP LEU SEQRES 27 A 360 PRO LYS GLU LYS LEU LYS GLU LEU ILE PHE GLU GLU THR SEQRES 28 A 360 ALA ARG PHE GLN PRO GLY TYR ARG SER MODRES 4ZXT CME A 161 CYS MODIFIED RESIDUE MODRES 4ZXT CME A 166 CYS MODIFIED RESIDUE MODRES 4ZXT CME A 254 CYS MODIFIED RESIDUE HET CME A 161 18 HET CME A 166 18 HET CME A 254 19 HET CAQ A 401 14 HET SO4 A 402 5 HET SO4 A 403 5 HET SO4 A 404 5 HET NH4 A 405 1 HET NH4 A 406 1 HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM CAQ CATECHOL HETNAM SO4 SULFATE ION HETNAM NH4 AMMONIUM ION HETSYN CAQ 1,2-DIHYDROXYBENZENE FORMUL 1 CME 3(C5 H11 N O3 S2) FORMUL 2 CAQ C6 H6 O2 FORMUL 3 SO4 3(O4 S 2-) FORMUL 6 NH4 2(H4 N 1+) FORMUL 8 HOH *299(H2 O) HELIX 1 AA1 HIS A 61 PHE A 78 1 18 HELIX 2 AA2 THR A 94 MET A 98 5 5 HELIX 3 AA3 LEU A 112 GLN A 119 1 8 HELIX 4 AA4 SER A 122 ALA A 143 1 22 HELIX 5 AA5 LYS A 151 SER A 153 5 3 HELIX 6 AA6 ASP A 175 ASP A 179 5 5 HELIX 7 AA7 THR A 190 ARG A 194 5 5 HELIX 8 AA8 ALA A 195 ASN A 201 1 7 HELIX 9 AA9 LYS A 207 ASN A 224 1 18 HELIX 10 AB1 HIS A 232 GLY A 245 1 14 HELIX 11 AB2 SER A 248 CME A 254 1 7 HELIX 12 AB3 ASN A 257 LEU A 267 1 11 HELIX 13 AB4 PRO A 274 PHE A 279 1 6 HELIX 14 AB5 ASP A 283 LEU A 294 1 12 HELIX 15 AB6 GLU A 303 ALA A 309 1 7 HELIX 16 AB7 HIS A 310 GLU A 314 5 5 HELIX 17 AB8 ASP A 318 GLU A 322 5 5 HELIX 18 AB9 PRO A 339 THR A 351 1 13 HELIX 19 AC1 ALA A 352 GLN A 355 5 4 SHEET 1 AA1 5 TYR A 25 GLU A 33 0 SHEET 2 AA1 5 MET A 38 ASP A 44 -1 O TYR A 43 N THR A 26 SHEET 3 AA1 5 VAL A 49 ILE A 56 -1 O VAL A 51 N ALA A 42 SHEET 4 AA1 5 VAL A 101 ASP A 106 -1 O VAL A 101 N ILE A 56 SHEET 5 AA1 5 ASP A 88 ILE A 90 -1 N ILE A 90 O TYR A 102 SHEET 1 AA2 3 THR A 110 ASP A 111 0 SHEET 2 AA2 3 LEU A 155 LEU A 157 -1 O LEU A 157 N THR A 110 SHEET 3 AA2 3 LEU A 163 ILE A 165 -1 O LYS A 164 N LEU A 156 SHEET 1 AA3 2 VAL A 145 LEU A 146 0 SHEET 2 AA3 2 ARG A 172 VAL A 173 -1 O ARG A 172 N LEU A 146 LINK C THR A 160 N CME A 161 1555 1555 1.33 LINK C CME A 161 N ASP A 162 1555 1555 1.33 LINK C ILE A 165 N CME A 166 1555 1555 1.33 LINK C CME A 166 N ASP A 167 1555 1555 1.32 LINK C ASN A 253 N CME A 254 1555 1555 1.34 LINK C CME A 254 N ILE A 255 1555 1555 1.32 SITE 1 AC1 4 ALA A 52 GLN A 105 ASP A 106 MET A 108 SITE 1 AC2 6 ARG A 191 ARG A 194 TYR A 233 HOH A 522 SITE 2 AC2 6 HOH A 535 HOH A 578 SITE 1 AC3 2 LYS A 207 HOH A 503 SITE 1 AC4 6 ASP A 124 TYR A 128 ILE A 256 ARG A 261 SITE 2 AC4 6 TYR A 316 HOH A 502 SITE 1 AC5 5 PRO A 247 SER A 248 ASP A 251 HOH A 579 SITE 2 AC5 5 HOH A 702 SITE 1 AC6 6 ASP A 179 SER A 202 GLY A 204 TYR A 205 SITE 2 AC6 6 THR A 206 HOH A 582 CRYST1 48.588 69.341 59.589 90.00 108.76 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020581 0.000000 0.006989 0.00000 SCALE2 0.000000 0.014421 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017723 0.00000